Home › Research › Risk genes beyond APOE
Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis
Bloom GS.. JAMA neurology, 2014-04-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The defining features of Alzheimer disease (AD) include conspicuous changes in both brain histology and behavior. The AD brain is characterized microscopically by the combined presence of 2 classes of abnormal structures, extracellular amyloid plaques and intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed filaments. The soluble building blocks of these structures are amyloid-β (Aβ) peptides for plaques and tau for tangles.
What this study adds
Evidence grade: Low
This is a narrative review. This 2014 review describes the two abnormal structures that define the Alzheimer's brain: amyloid plaques outside nerve cells, built from amyloid-β (a fragment of the amyloid precursor protein), and tangles inside them, built from tau. It states that symptoms "correlate with the accumulation of plaques and tangles" and are "a direct consequence of the damage and destruction of synapses that mediate memory and cognition".
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Bloom, G. S. (2014). Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA neurology. https://doi.org/10.1001/jamaneurol.2013.5847
Vancouver
Bloom GS. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA neurology. 2014. doi:10.1001/jamaneurol.2013.5847. PMID: 24493463.
BibTeX
@article{bloom2014-24493463,
author = {Bloom, G. S.},
title = {{Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis}},
journal = {JAMA neurology},
year = {2014},
doi = {10.1001/jamaneurol.2013.5847},
pmid = {24493463},
url = {https://doi.org/10.1001/jamaneurol.2013.5847}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The AD brain is characterized microscopically by the combined presence of 2 classes of abnormal structures, extracellular amyloid plaques and intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed filaments.
- The soluble building blocks of these structures are amyloid-β (Aβ) peptides for plaques and tau for tangles.
- Amyloid-β peptides are proteolytic fragments of the transmembrane amyloid precursor protein, whereas tau is a brain-specific, axon-enriched microtubule-associated protein.
- The behavioral symptoms of AD correlate with the accumulation of plaques and tangles, and they are a direct consequence of the damage and destruction of synapses that mediate memory and cognition.
Why it matters
This 2014 review describes the two abnormal structures that define the Alzheimer's brain: amyloid plaques outside nerve cells, built from amyloid-β (a fragment of the amyloid precursor protein), and tangles inside them, built from tau. It states that symptoms "correlate with the accumulation of plaques and tangles" and are "a direct consequence of the damage and destruction of synapses that mediate memory and cognition". It presents no new data, and our record does not explain its title's idea of amyloid-β and tau as "the trigger and bullet", so treat that as the author's framing, not a tested result.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 55/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA neurology) |
| Journal's citation record | 2 / 4 | JAMA Neurology: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2014 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 2,185 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 156.1 citations a year over 14 year(s) since 2014 |
| Impact for its field and year | 6 / 6 | Cited 44.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 49 other studies in this library |
| Still being cited | 4 / 4 | Cited 786 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author George S. Bloom: h-index 52 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Virginia: institution h-index 1,118 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 24493463) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamaneurol.2013.5847
- PubMed: 24493463
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
49 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Risk genes beyond APOE from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.